Nihon Kohden Corporation

TSE:6849 Stock Report

Market Cap: JP¥356.1b

Nihon Kohden Valuation

Is 6849 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6849 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6849 (¥2153) is trading below our estimate of fair value (¥2624.83)

Significantly Below Fair Value: 6849 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6849?

Key metric: As 6849 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 6849. This is calculated by dividing 6849's market cap by their current earnings.
What is 6849's PE Ratio?
PE Ratio37.5x
EarningsJP¥9.49b
Market CapJP¥356.09b

Price to Earnings Ratio vs Peers

How does 6849's PE Ratio compare to its peers?

The above table shows the PE ratio for 6849 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17x
6960 Fukuda Denshi
12.2x5.6%JP¥201.8b
7716 Nakanishi
23.3x11.2%JP¥202.1b
7817 Paramount Bed Holdings
20.5x15.4%JP¥156.0b
7575 Japan Lifeline
11.9x6.8%JP¥93.9b
6849 Nihon Kohden
37.5x20.1%JP¥356.1b

Price-To-Earnings vs Peers: 6849 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the peer average (17x).

Price to Earnings Ratio vs Industry

How does 6849's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
6849 37.5xIndustry Avg. 15.8xNo. of Companies7PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 6849 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the JP Medical Equipment industry average (15.8x).

Price to Earnings Ratio vs Fair Ratio

What is 6849's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6849 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio37.5x
Fair PE Ratio27.9x

Price-To-Earnings vs Fair Ratio: 6849 is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the estimated Fair Price-To-Earnings Ratio (27.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6849 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥2,148.00
JP¥2,378.57
+10.7%
24.0%JP¥3,500.00JP¥1,700.00n/a7
Dec ’25JP¥2,126.50
JP¥2,378.57
+11.9%
24.0%JP¥3,500.00JP¥1,700.00n/a7
Nov ’25JP¥2,234.00
JP¥2,190.00
-2.0%
27.4%JP¥3,500.00JP¥1,700.00n/a7
Oct ’25JP¥2,142.50
JP¥2,210.00
+3.2%
27.6%JP¥3,600.00JP¥1,700.00n/a8
Sep ’25JP¥1,960.50
JP¥2,260.00
+15.3%
25.7%JP¥3,600.00JP¥1,700.00n/a8
Aug ’25JP¥2,234.00
JP¥2,537.50
+13.6%
21.4%JP¥3,600.00JP¥1,850.00n/a8
Jul ’25JP¥2,308.50
JP¥2,412.86
+4.5%
18.5%JP¥3,250.00JP¥1,850.00n/a7
Jun ’25JP¥2,397.50
JP¥2,228.00
-7.1%
16.5%JP¥2,700.00JP¥1,850.00n/a5
May ’25JP¥2,159.00
JP¥2,232.50
+3.4%
17.6%JP¥2,700.00JP¥1,650.00n/a6
Apr ’25JP¥2,000.00
JP¥2,149.00
+7.5%
17.6%JP¥2,700.00JP¥1,650.00n/a5
Mar ’25JP¥2,095.00
JP¥2,174.00
+3.8%
15.9%JP¥2,700.00JP¥1,775.00n/a5
Feb ’25JP¥2,248.00
JP¥2,031.00
-9.7%
16.0%JP¥2,450.00JP¥1,650.00n/a5
Jan ’25JP¥2,231.50
JP¥2,031.00
-9.0%
16.0%JP¥2,450.00JP¥1,650.00n/a5
Dec ’24JP¥1,859.50
JP¥2,031.00
+9.2%
16.0%JP¥2,450.00JP¥1,650.00JP¥2,126.505
Nov ’24JP¥1,810.00
JP¥2,045.00
+13.0%
15.7%JP¥2,450.00JP¥1,650.00JP¥2,234.005
Oct ’24JP¥1,846.00
JP¥2,045.00
+10.8%
15.7%JP¥2,450.00JP¥1,650.00JP¥2,142.505
Sep ’24JP¥1,950.50
JP¥2,045.00
+4.8%
15.7%JP¥2,450.00JP¥1,650.00JP¥1,960.505
Aug ’24JP¥1,867.00
JP¥2,035.00
+9.0%
15.3%JP¥2,450.00JP¥1,650.00JP¥2,234.005
Jul ’24JP¥1,921.00
JP¥1,991.67
+3.7%
15.1%JP¥2,450.00JP¥1,650.00JP¥2,308.506
Jun ’24JP¥1,875.00
JP¥2,033.33
+8.4%
17.7%JP¥2,600.00JP¥1,650.00JP¥2,397.506
May ’24JP¥1,922.50
JP¥1,929.17
+0.3%
18.6%JP¥2,600.00JP¥1,525.00JP¥2,159.006
Apr ’24JP¥1,795.00
JP¥1,929.17
+7.5%
18.6%JP¥2,600.00JP¥1,525.00JP¥2,000.006
Mar ’24JP¥1,692.50
JP¥1,929.17
+14.0%
18.6%JP¥2,600.00JP¥1,525.00JP¥2,095.006
Feb ’24JP¥1,667.50
JP¥1,954.17
+17.2%
20.2%JP¥2,700.00JP¥1,525.00JP¥2,248.006
Jan ’24JP¥1,602.50
JP¥1,925.00
+20.1%
20.7%JP¥2,650.00JP¥1,500.00JP¥2,231.506
Dec ’23JP¥1,582.50
JP¥1,925.00
+21.6%
20.7%JP¥2,650.00JP¥1,500.00JP¥1,859.506

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 16:43
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nihon Kohden Corporation is covered by 21 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masahiro NakanomyoBarclays
Craig NelsonBNP Paribas Securities (Asia)
Zhijie ZhaoCLSA